{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:39:25Z","timestamp":1790959165123,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.phrs.2024.107129","type":"journal-article","created":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T03:38:28Z","timestamp":1709955508000},"page":"107129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["IUPHAR ECR review: Cancer-related anorexia-cachexia in cancer patients: Pathophysiology and treatment"],"prefix":"10.1016","volume":"203","author":[{"given":"Iftekhar Hossain","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamima","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeasmin Jahan","family":"Afroze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmeen Tania","family":"Shovah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2024.107129_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1586\/14737140.3.3.381","article-title":"Cancer-related cachexia and oxidative stress: beyond current therapeutic options","volume":"3","author":"Mantovani","year":"2003","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"11","key":"10.1016\/j.phrs.2024.107129_bib2","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S1470-2045(03)01247-6","article-title":"Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies","volume":"4","author":"Laviano","year":"2003","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.phrs.2024.107129_bib3","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.psyneuen.2010.02.003","article-title":"Parathyroid hormone-related protein has an anorexigenic activity via activation of hypothalamic urocortins 2 and 3","volume":"35","author":"Asakawa","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.phrs.2024.107129_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00520-009-0800-6","article-title":"European palliative care research collaborative. Evolving classification systems for cancer cachexia: ready for clinical practice?","volume":"18","author":"Blum","year":"2010","journal-title":"Support. care Cancer"},{"issue":"10","key":"10.1016\/j.phrs.2024.107129_bib5","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0899-9007(00)00413-5","article-title":"Central nervous system mechanisms contributing to the cachexia\u2013anorexia syndrome","volume":"16","author":"Plata-Salam\u00e1n","year":"2000","journal-title":"Nutrition"},{"issue":"4","key":"10.1016\/j.phrs.2024.107129_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.mco.0000134373.16557.92","article-title":"Interleukin-1\u03b2 system in anorectic catabolic tumor-bearing rats","volume":"7","author":"Turrin","year":"2004","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.phrs.2024.107129_bib7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2165\/00003495-200161040-00004","article-title":"Managing cancer-related anorexia\/cachexia","volume":"61","author":"Mantovani","year":"2001","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.phrs.2024.107129_bib8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1172\/JCI118398","article-title":"Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice","volume":"97","author":"Tsujinaka","year":"1996","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.phrs.2024.107129_bib9","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1210\/en.2003-0241","article-title":"Minireview: from anorexia to obesity\u2014the yin and yang of body weight control","volume":"144","author":"Zigman","year":"2003","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.phrs.2024.107129_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0166-2236(98)01292-2","article-title":"Feeding and body-weight regulation by hypothalamic neuropeptides\u2014mediation of the actions of leptin","volume":"22","author":"Inui","year":"1999","journal-title":"Trends Neurosci."},{"issue":"6925","key":"10.1016\/j.phrs.2024.107129_bib11","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nature01388","article-title":"STAT3 signalling is required for leptin regulation of energy balance but not reproduction","volume":"421","author":"Bates","year":"2003","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2024.107129_bib12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0196-9781(96)00016-2","article-title":"Neuropeptide Y blocks and reverses interleukin-1\u03b2-induced anorexia in rats","volume":"17","author":"Sonti","year":"1996","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.phrs.2024.107129_bib13","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/cncr.2820690532","article-title":"Megestrol acetate in cancer anorexia and weight loss","volume":"69","author":"Tchekmedyian","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.phrs.2024.107129_bib14","article-title":"Appetite problem in cancer patients: pathophysiology, diagnosis, and treatment","volume":"27","author":"Hariyanto","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"issue":"6","key":"10.1016\/j.phrs.2024.107129_bib15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1159\/000346446","article-title":"Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide","volume":"58","author":"Wen","year":"2013","journal-title":"Chemotherapy"},{"issue":"2","key":"10.1016\/j.phrs.2024.107129_bib16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.2002.20.2.567","article-title":"Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study","volume":"20","author":"Jatoi","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.phrs.2024.107129_bib17","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1200\/JCO.1999.17.10.3299","article-title":"Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia\/cachexia","volume":"17","author":"Loprinzi","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2024.107129_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11864-010-0127-z","article-title":"Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment","volume":"11","author":"Kumar","year":"2010","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.phrs.2024.107129_bib19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00023210-200923050-00006","article-title":"Mirtazapine: a review of its use in major depression and other psychiatric disorders","volume":"23","author":"Croom","year":"2009","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.phrs.2024.107129_bib20","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0885-3924(02)00381-0","article-title":"An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms","volume":"23","author":"Theobald","year":"2002","journal-title":"J. Pain. symptom Manag."},{"issue":"2","key":"10.1016\/j.phrs.2024.107129_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/1049909109345685","article-title":"Phase II trial of mirtazapine for cancer-related cachexia and anorexia","volume":"27","author":"Riechelmann","year":"2010","journal-title":"Am. J. Hosp. Palliat. Med. \u00ae"},{"key":"10.1016\/j.phrs.2024.107129_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00787-007-0670-8","article-title":"Mirtazapine in the treatment of adolescent anorexia nervosa: case\u2013control study","volume":"17","author":"Hrdlicka","year":"2008","journal-title":"Eur. Child Adolesc. Psychiatry"},{"issue":"5","key":"10.1016\/j.phrs.2024.107129_bib23","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.12-5-594","article-title":"Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers","volume":"12","author":"Garcia","year":"2007","journal-title":"oncologist"},{"issue":"11-12","key":"10.1016\/j.phrs.2024.107129_bib24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2298\/MPNS0812571S","article-title":"Influence of dexamethasone on appetite and body weight in lung cancer patients","volume":"61","author":"\u0160ar\u010dev","year":"2008","journal-title":"Med. Pregl."},{"issue":"3","key":"10.1016\/j.phrs.2024.107129_bib25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.173.3.699","article-title":"Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes","volume":"173","author":"Sampaio","year":"1991","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.phrs.2024.107129_bib26","first-page":"3604","article-title":"Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid","volume":"61","author":"Whitehouse","year":"2001","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.phrs.2024.107129_bib27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bjc.6602725","article-title":"Angiotensin II directly induces muscle protein catabolism through the ubiquitin\u2013proteasome proteolytic pathway and may play a role in cancer cachexia","volume":"93","author":"Sanders","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.phrs.2024.107129_bib28","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jpainsymman.2021.05.017","article-title":"Mirtazapine in cancer-associated anorexia and cachexia: a double-blind placebo-controlled randomized trial","volume":"62","author":"Hunter","year":"2021","journal-title":"J. Pain. Symptom Manag."},{"issue":"4","key":"10.1016\/j.phrs.2024.107129_bib29","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/ajcn\/83.4.735","article-title":"Cachexia: pathophysiology and clinical relevance.","volume":"83","author":"Morley","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2024.107129_bib30","doi-asserted-by":"crossref","first-page":"hyae009","DOI":"10.1093\/jjco\/hyae009","article-title":"Mirtazapine versus megestrol acetate in treatment of anorexia-cachexia in advanced cancer patients: a randomized, double-blind trial","author":"Chowdhury","year":"2024","journal-title":"Jpn. J. Clin. Oncol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824000732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824000732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T03:01:19Z","timestamp":1714273279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824000732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":30,"alternative-id":["S1043661824000732"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107129","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IUPHAR ECR review: Cancer-related anorexia-cachexia in cancer patients: Pathophysiology and treatment","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107129"}}